Helix BioMedix regulatory update

HXBM (Baton Rouge, La.) said two European patents (Nos. 365,598 and 383,770) were issued to Louisiana State University covering HXBM's anti-infective and anti-cancer peptides. HXBM has exclusive worldwide rights to both patents.

The '598 patent covers applications of cecropin and cecropin derivatives to treat diseases caused by yeast, fungal or protozoan infections. Cecropins are peptides found in the immune system of the giant silk moth Hylaphora cecropia. ...